906PD - Phase III trial of adjuvant sunitinib in patients with high-risk renal cell carcinoma: Comprehensive tumour genomic and transcriptomic analyses

Autor: Ravaud, A., Martini, J.-F., Ching, K., Staehler, M., Magheli, A., Escudier, B., Mu, X.J., Valota, O., Lin, X., Motzer, R.J.
Zdroj: In Annals of Oncology October 2019 30 Supplement 5:v358-v359
Databáze: ScienceDirect